ROSEN, SKILLED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

Core Viewpoint - A class action lawsuit has been filed against Boston Scientific Corporation for allegedly making misleading statements regarding its U.S. Electrophysiology segment, leading to investor losses during the Class Period from July 23, 2025, to February 3, 2026 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Boston Scientific's management was aware that the growth rate of its U.S. Electrophysiology segment was unsustainable, yet they continued to provide positive statements to investors [5]. - Investors were surprised by Boston Scientific's net income miss and underwhelming guidance for the first half of fiscal 2026, which the lawsuit attributes to the misleading statements made by the defendants [5]. Group 2: Participation Information - Investors who purchased Boston Scientific common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its leadership in securities class action settlements, being ranked No. 1 by ISS Securities Class Action Services in 2017 and consistently in the top 4 since 2013 [4].